Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 11, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 March 2026 - 16:14

Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 11, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/quviviq

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters